View in EDS

Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial.

Saved in:
Bibliographic Details
Title: Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial.
Authors: Hohlfeld JM; Fraunhofer Institute for Toxicology and Experimental Medicine and Hannover Medical School, Member of the German Center for Lung Research, Hannover, Germany., Badorrek P; Fraunhofer Institute for Toxicology and Experimental Medicine and Hannover Medical School, Member of the German Center for Lung Research, Hannover, Germany., Breuer O; EpiEndo Pharmaceuticals, Bjargargata 1, 102, Reykjavik, Iceland., Hanrott K; EpiEndo Pharmaceuticals, Bjargargata 1, 102, Reykjavik, Iceland., Kricker J; EpiEndo Pharmaceuticals, Bjargargata 1, 102, Reykjavik, Iceland., Parnham MJ; EpiEndo Pharmaceuticals, Bjargargata 1, 102, Reykjavik, Iceland., Norris V; EpiEndo Pharmaceuticals, Bjargargata 1, 102, Reykjavik, Iceland. Electronic address: ginny.norris@epiendo.com.
Source: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2025 Sep; Vol. 90, pp. 102365. Date of Electronic Publication: 2025 Jun 03.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Academic Press Country of Publication: England NLM ID: 9715279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-9629 (Electronic) Linking ISSN: 10945539 NLM ISO Abbreviation: Pulm Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40466859
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hohlfeld+JM%22">Hohlfeld JM</searchLink>; Fraunhofer Institute for Toxicology and Experimental Medicine and Hannover Medical School, Member of the German Center for Lung Research, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Badorrek+P%22">Badorrek P</searchLink>; Fraunhofer Institute for Toxicology and Experimental Medicine and Hannover Medical School, Member of the German Center for Lung Research, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Breuer+O%22">Breuer O</searchLink>; EpiEndo Pharmaceuticals, Bjargargata 1, 102, Reykjavik, Iceland.<br /><searchLink fieldCode="AU" term="%22Hanrott+K%22">Hanrott K</searchLink>; EpiEndo Pharmaceuticals, Bjargargata 1, 102, Reykjavik, Iceland.<br /><searchLink fieldCode="AU" term="%22Kricker+J%22">Kricker J</searchLink>; EpiEndo Pharmaceuticals, Bjargargata 1, 102, Reykjavik, Iceland.<br /><searchLink fieldCode="AU" term="%22Parnham+MJ%22">Parnham MJ</searchLink>; EpiEndo Pharmaceuticals, Bjargargata 1, 102, Reykjavik, Iceland.<br /><searchLink fieldCode="AU" term="%22Norris+V%22">Norris V</searchLink>; EpiEndo Pharmaceuticals, Bjargargata 1, 102, Reykjavik, Iceland. Electronic address: ginny.norris@epiendo.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229715279%22">Pulmonary pharmacology & therapeutics</searchLink> [Pulm Pharmacol Ther] 2025 Sep; Vol. 90, pp. 102365. <i>Date of Electronic Publication: </i>2025 Jun 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academic+Press%22">Academic Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9715279 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1522-9629 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210945539%22">10945539 </searchLink><i>NLM ISO Abbreviation: </i>Pulm Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40466859
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.pupt.2025.102365
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102365
    Titles:
      – TitleFull: Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hohlfeld JM
      – PersonEntity:
          Name:
            NameFull: Badorrek P
      – PersonEntity:
          Name:
            NameFull: Breuer O
      – PersonEntity:
          Name:
            NameFull: Hanrott K
      – PersonEntity:
          Name:
            NameFull: Kricker J
      – PersonEntity:
          Name:
            NameFull: Parnham MJ
      – PersonEntity:
          Name:
            NameFull: Norris V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2025 Sep
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1522-9629
          Numbering:
            – Type: volume
              Value: 90
          Titles:
            – TitleFull: Pulmonary pharmacology & therapeutics
              Type: main
ResultId 1